Apogee Therapeutics, Inc. (NASDAQ:APGE) has 203 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 31 Mar, 2026 | 10,300,984 | 6,012,541 | 140.20% | $867,034.00 |
| FMR LLC | 31 Mar, 2026 | 9,262,291 | 1,037,253 | 12.61% | $779,606,994.00 |
| VR Adviser, LLC | 31 Mar, 2026 | 8,493,321 | 0 | 0.00% | $641,075,869.00 |
| Venrock Adviser, LLC | 31 Mar, 2026 | 8,493,321 | 0 | 0.00% | $714,882,829.00 |
| FMR LLC | 31 Mar, 2026 | 8,225,038 | 1,308,576 | 18.92% | $620,825,834.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 4,746,585 | 22,884 | 0.48% | $358,272,236.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 4,721,192 | 2,658,588 | 128.89% | $397,617,768.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 4,375,703 | -370,882 | -7.81% | $368,302,921.00 |
| T. Rowe Price Investment Management, Inc. | 31 Mar, 2026 | 4,288,443 | 4,287,002 | 297,501.88% | $323,692.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 4,085,651 | 301,657 | 7.97% | $343,889,202.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 3,783,994 | 1,097,968 | 40.88% | $285,615,865.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 2,857,824 | 612,193 | 27.26% | $215,708,556.00 |
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 2,782,097 | 70,000 | 2.58% | $234,169,104.00 |
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 2,712,097 | 0 | 0.00% | $204,709,082.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,502,095 | 2,502,095 | 0.00% | $210,601,336.00 |
| PERCEPTIVE ADVISORS LLC | 31 Mar, 2026 | 2,330,651 | 978,662 | 72.39% | $175,917,537.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,183,704 | 25,202 | 1.17% | $164,825,978.00 |
| State Street Corp | 31 Mar, 2026 | 2,162,964 | 472,778 | 27.97% | $182,056,680.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 2,062,604 | 1,576,626 | 324.42% | $155,697,275.00 |
| Fairmount Funds Management LLC | 31 Mar, 2026 | 2,048,647 | 0 | 0.00% | $154,631,876.00 |